Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

Boehringer Starts Phase II Trial for Oral Drug in...

Boehringer Starts Phase II Trial for Oral Drug in...

Category : Clinical Trial Update 9 May 2025

Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investig...

Everest Medicines Announces NMPA Full Approval of...

Everest Medicines Announces NMPA Full Approval of...

Category : Approval/Launch 8 May 2025

Everest Medicines a biopharmaceutical company focused on the discovery, clinical development, manufa...

Lilly Deepens ALS Pipeline With $415M Alchemab Lic...

Lilly Deepens ALS Pipeline With $415M Alchemab Lic...

Category : Licensing/Collaboration Deal 8 May 2025

The Alchemab deal will further strengthen Lilly’s early-stage pipeline for amyotrophic lateral...

Data from Its Ongoing Phase 2 ENSURE Study at EASL...

Data from Its Ongoing Phase 2 ENSURE Study at EASL...

Category : Clinical Trial Update 8 May 2025

End of treatment (EOT) data from Cohort 4 of the ENSURE study suggest that patients responding to pr...

Genprex inks sponsored research agreement with the...

Genprex inks sponsored research agreement with the...

Category : Clinical Trial Update 8 May 2025

Genprex, Inc. (Genprex), a clinical-stage gene therapy company, announced that following the recent...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.